Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

LRMR

LRMR News

Newswire

11:21

Larimar Therapeutics shares surge 10.58% intraday on positive Nomlabofusp study data and FDA BLA submission updates for Friedreich’s Ataxia.

14:43

Larimar shares surge 10.25% intraday as company promotes green amber pendants with free worldwide delivery.

06:05

Larimar Therapeutics Reports Positive Friedreich's Ataxia Treatment Data, Adjusts Dosing Regimen for Anaphylactic Risks

06:04

LRMR Financial Outlook: Robust Cash Position Extends Runway

07:36

Nomlabofusp shows potential in treating Friedreich's ataxia, with 100% of participants achieving normal skin FXN levels.

View More

About LRMR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More